Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

TitleGynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.
Publication TypeJournal Article
Year of Publication2014
AuthorsHasegawa, K, Nagao, S, Yasuda, M, Millan, D, Viswanathan, A, Glasspool, RM, Devouassoux-Shisheboran, M, Covens, A, Lorusso, D, Kurzeder, C, Kim, J-W, Gladieff, L, Bryce, J, Friedlander, MLeonard, Fujiwara, K
JournalInt J Gynecol Cancer
Volume24
Issue9 Suppl 3
PaginationS90-5
Date Published11/2014
ISSN1525-1438
KeywordsAdenocarcinoma, Clear Cell, Combined Modality Therapy, Consensus, Female, Humans, Medical Oncology, Ovarian Neoplasms, Practice Guidelines as Topic, Societies, Medical, Uterine Neoplasms
Abstract

Clear cell carcinomas of the uterine corpus and cervix are rare gynecological cancers with limited information regarding the pathogenesis and biology. At present, the approach to management is the same as for patients with the more common histological subtypes of endometrioid endometrial cancer and adenocarcinoma of the cervix. Surgical resection is the standard treatment for patients with early-stage disease, but there is no evidence-based approach to direct the management of patients with more advanced-stage disease at presentation or with recurrent disease. We review the epidemiology, pathology, and what is known about both uterine corpus and cervical clear cell cancers and make management recommendations.

DOI10.1097/IGC.0000000000000297
Alternate JournalInt. J. Gynecol. Cancer
PubMed ID25341588